Cocrystal Pharma, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
Cocrystal Pharma files S-1 to register 5.7 million shares for resale by selling stockholders, while disclosing substantial doubt about its ability to continue as a going concern.